Fireside chat: advancing analytical science and regulatory readiness for nucleic acid medicines
Nucleic Acid Insights · 15.06.2026 · 3 (5) · 316–324
DOI: 10.18609/nuc.2026.037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acid Insights, online erschienen am 15.06.2026. Verfasst von Jonathan Neidigh und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
“LC-MS of oligonucleotides has advanced considerably and is approaching a level of maturity where more routine use outside R&D settings should be feasible.” Jonathan Neidigh (CMC Consultant) and Michael Bartlett (Professor, University of Georgia) discuss the analytical and regulatory challenges facing the field, exploring key gaps in impurity characterization and method development, the limitations of current chromatographic platforms in quality control settings, and the value of closer collaboration between academic and industry scientists.
Zitieren
APA
Neidigh, J., & Bartlett, M. (2026). Fireside chat: advancing analytical science and regulatory readiness for nucleic acid medicines. Nucleic Acid Insights, 3(5), 316–324. https://doi.org/10.18609/nuc.2026.037
Vancouver
Neidigh J, Bartlett M. Fireside chat: advancing analytical science and regulatory readiness for nucleic acid medicines. Nucleic Acid Insights. 2026;3(5):316–324. doi:10.18609/nuc.2026.037
BibTeX
@article{Neidigh2026,
author = {Neidigh, Jonathan and Bartlett, Michael},
title = {Fireside chat: advancing analytical science and regulatory readiness for nucleic acid medicines},
journal = {Nucleic Acid Insights},
year = {2026},
volume = {3},
number = {5},
pages = {316–324},
doi = {10.18609/nuc.2026.037}
}
EUVIMED